0.99 USD
↘ 0.03 (2.83%)AT CLOSE (11:59 AM EDT)
Lucid Diagnostics Inc. Common Stock
LUCDNASDAQ • USD
1.02
↗ 0.03 (3.02%)
POST MARKET (AS OF 07:58 PM EDT)
Post Market
AS OF 07:58 PM EDT
1.02
↗ 0.03 (3.02%)
Market: CLOSED
Open?$1.01
High?$1.03
Low?$0.95
Prev. Close?$1.02
Volume?1.4M
Avg. Volume?888.0K
VWAP?$0.99
Rel. Volume?1.55x
Bid / Ask
Bid?$1.00 × 300
Ask?$1.03 × 200
Spread?$0.04
Midpoint?$1.01
Valuation & Ratios
Market Cap?188.8M
Shares Out?195.3M
Float?150.5M
Float %?77.1%
P/E Ratio?N/A
P/B Ratio?47.21
EPS?-$0.30
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
Themes
Employees
82
Market Cap
189.1M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Website
Listed
2021-10-14
Address
360 MADISON AVENUE
NEW YORK, NY 10017
Phone: 212 949 4319
NEW YORK, NY 10017
Phone: 212 949 4319
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?1.07Adequate
Quick Ratio?1.05Adequate
Cash Ratio?0.95Adequate
Debt/Equity?6.30High
ValuationRICHLY VALUED
Score50/100
P/E?N/A▾
P/B?47.21HIGH▾
P/S?36.78HIGH▾
P/FCF?N/A▾
EV/EBITDA?-3.9CHEAP▾
EV/Sales?36.26HIGH▾
Returns & Efficiency
ROE?-1,454.5%WEAK▾
ROA?-170.7%WEAK▾
Cash Flow & Enterprise
FCF?$-46440000
Enterprise Value?$186.2M
Fundamentals ratios updated end of day